Default company panoramic image

Curionic Biotherapeutics

Controlled delivery of bioactive therapeutics for post-heart attack cardiac repair

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded September 2010
  • Employees 2

Company Summary

This platform technology allows for controlled release of protein therapeutics to specific tissues over time. It has been proven effective for post heart attack recovery, with additional indications for wound healing, chemotherapeutics, and neurodegenerative diseases. The global market for biopharmaceutical proteins will exceed $155 billion by 2015, many of which will rely on a delivery system to localize them and extend their release over time.


  • Default avatar
    Noah Johnson
    Co-Director of Research & Development

    Current education: PhD in Bioengineering at University of Pittsburgh
    Previous education: B.S. in Bioengineering at The Pennsylvania State University
    E-mail: [email protected]
    Phone: 814-441-2037
    Local Address: 5562 Hobart St. B4, Pittsburgh, PA 15217
    Home Address: 733 W. Foster Ave., State College, PA 16801

  • Default avatar
    Hunghao Chu
    Co-Director of Research & Development

    Previous education: B.S. in Chemistry at National Taiwan Univ. in 2003, M.S. in Molecular and Cell Biology at National Tsing Hua Univ in 2005, and PhD in Bioengineering at University of Pittsburgh in 2011
    E-mail: [email protected]
    Phone: 404-824-5227
    Local Address: 5420 Ellsworth Ave. Apt.11 Pittsburgh PA 15232
    Home Address: 2621 Hibiscus Way Apt.311 Beavercreek OH45431